0 CHECKOUT

In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020

  • ID: 3641399
  • February 2016
  • Region: Global
  • 149 pages
  • Allied Analytics LLP
1 of 5
Global Sales of IVF Devices and Consumables is Projected to Reach $3 Billion by 2020

FEATURED COMPANIES

  • Auxogyn Inc.
  • Cook Medical Inc.
  • CooperSurgical
  • EMD Serono
  • Genea Biomedx
  • Irvine Scientific
  • MORE

In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is a widely popular treatment, adopted by couples with infertility problems, single mothers, and the LGBT community to procreate.

The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Auxogyn Inc.
  • Cook Medical Inc.
  • CooperSurgical
  • EMD Serono
  • Genea Biomedx
  • Irvine Scientific
  • MORE

CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key market benefits
1.3 Key market segments
1.4 Key audiences
1.5 Research methodology
1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 Intrauterine Insemination (IUI) Technique
3.2.1.1 Factors assessed for the procedure
3.2.1.2 Benefits of this technique
3.2.1.3 Risks
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
3.2.3.1 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
3.3.1.1 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.2 Egg sharing
3.5.3 Sperm donation
3.5.4 Embryo donation/adoption
3.5.5 Donation for research
3.6 Surrogacy
3.6.1 Legal issues
3.7 IVF trends in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced IVF technologies
3.8.1 Capsule IVF
3.8.2 Three parent IVF
3.8.2.1 Ethical concerns
3.8.3 Mini IVF
3.8.3.1 Advantages
3.8.3.2 Drawbacks
3.8.4 EmbryoScope
3.8.4.1 Advantages
3.8.5 PICSI
3.9 Fertility treatment and gender selection
3.9.1 Methods of sex selection
3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Key Findings
3.13.1 Top factors impacting
3.13.2 Top investment pockets
3.13.3 Top winning strategies
3.14 Porters five forces analysis
3.14.1 High competition and large number reduces the power of suppliers
3.14.2 Scattered nature and large count of end users moderates the buyer power
3.14.3 High capital cost lowers the threat of new entrants
3.14.4 Industry rivalry is intense due to presence of few dominant competitors
3.14.5 Lack of efficient substitutes lowers the threat from substitutes
3.15 Value chain analysis
3.16 Patent analysis
3.16.1 Patent analysis by type of patents
3.16.2 Patents Analysis by geography
3.17 Regulatory issues and legislations
3.18 Insurance reimbursement scenario
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20 Drivers
3.20.1 Delayed pregnancies in women
3.20.2 Rise in global infertility rates
3.20.3 Advancement in technology
3.20.4 Rise in gamete donations
3.20.5 Rise in disposable income
3.20.6 Increase in success rates
3.21 Restraints
3.21.1 Cost constraints
3.21.2 Ethical and legal issues
3.21.3 Multiple pregnancies
3.21.4 Low awareness level
3.22 Opportunities
3.22.1 Fertility tourism
3.22.2 Growing number of fertility clinics
3.22.3 Rise in same sex marriages

CHAPTER 4 GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS
4.1 Global IVF market by instrument, 2014-2020, ($million)
4.1.1 Incubators
4.1.1.1 Global IVF incubators market by geography
4.1.2 Cryosystem
4.1.2.1 Global IVF cryosystem market by geography
4.1.3 Imaging system
4.1.3.1 Global IVF Imaging system market by geography
4.1.4 Cabinet (work station)
4.1.4.1 Global IVF cabinets market by geography
4.1.5 Ovum aspiration pump
4.1.5.1 Global IVF ovum aspiration pump market by geography
4.1.6 Sperm separation system
4.1.6.1 Global IVF Sperm separation system market by geography
4.1.7 Micro manipulator system
4.1.7.1 Global IVF Micromanipulator market by geography
4.1.8 Others
4.1.8.1 Global IVF other instruments market by geography
4.2 Accessories and disposables
4.2.1 Semen analysis chamber
4.2.2 Plastic ware
4.2.3 Oocyte retrieval needles
4.2.4 Miscellaneous disposables
4.2.5 Global IVF accessories and disposables market by geography

CHAPTER 5 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA
5.1 Global IVF market by reagents & media, 2014-2020, ($million)
5.2 Cryopreservation media
5.2.1 Embryo cryopreservation media
5.2.2 Sperm cryopreservation media
5.2.3 Oocyte cryopreservation media
5.2.4 Global IVF cryopreservation media market by geography
5.3 Semen processing media
5.3.1 Global IVF semen processing media market by geography
5.4 Ovum processing media
5.4.1 Global IVF ovum processing media market by geography
5.5 Embryo culture media
5.5.1 Global IVF embryo culture media market by geography

CHAPTER 6 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE
6.1 Global IVF market, by technique, 2014-2020 ($Million)
6.2 Fresh embryo transfer technique
6.2.1 Drivers
6.2.1.1 trends of Delayed pregnancies
6.2.1.2 Growing rates of infertility
6.2.2 Restraints
6.2.2.1 Cost involved in the treatment
6.2.2.2 reimbursements issues with fresh embryo ivf cycles
6.2.3 Global fresh embryo IVF cycle market, by geography
6.3 Frozen Embryo Transfer technique (FER)
6.3.1 Reasons to use this technique
6.3.2 Advantages of Frozen egg IVF technique
6.3.3 Disadvantages of frozen egg IVF technique
6.3.4 Global frozen egg IVF cycle market, by geography
6.4 Donor Egg IVF technique
6.4.1 Benefits of donor egg IVF technique
6.4.2 Risks associated with donor egg IVF cycle technique
6.4.3 Global donor egg IVF cycle market by geography

CHAPTER 7 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS
7.1 Global IVF market by end user, 2014-2020 ($Million)
7.2 Hospitals
7.2.1 Global IVF hospitals market by geography
7.3 Surgical centers
7.4 Clinical research institutes
7.4.1 Global IVF clinical research institutes market by geography
7.5 Clinics
7.5.1 Global IVF Clinics market by geography

CHAPTER 8 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 North America IVF devices and consumables market, by country
8.1.1.1 United States IVF devices and consumables market
8.1.1.2 Canada IVF devices and consumables market
8.1.1.3 Mexico IVF devices and consumables market
8.2 Europe
8.2.1 Europe IVF devices and consumables market, by component
8.2.1.1 Germany IVF devices and consumables market
8.2.1.2 France IVF devices and consumables market
8.2.1.3 United Kingdom IVF devices and consumables market
8.2.1.4 Other Europe IVF devices and consumables market
8.3 Asia-Pacific
8.3.1 Asia-Pacific IVF devices & consumables market, by component
8.3.1.1 India IVF devices & consumables market
8.3.1.2 China IVF devices & consumables market
8.3.1.3 Japan IVF devices & consumables market
8.3.1.4 Australia IVF devices & consumables market
8.3.1.5 other Asia-pacific IVF devices & consumables market
8.4 LAMEA
8.4.1 LAMEA IVF devices & consumables market, by component
8.4.1.1 Latin America IVF devices & consumables market
8.4.1.2 Middle East IVF devices & consumables market
8.4.1.3 Africa IVF devices & consumables market

CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Business performance
9.1.3 Strategic moves and developments
9.1.4 SWOT analysis of Vitrolife AB
9.2 EMD Serono, Inc.
9.2.1 Company overview
9.2.2 Business performance
9.2.3 Strategic moves and developments
9.2.4 SWOT analysis of EMD Serono, Inc.
9.3 Irvine Scientific
9.3.1 Company overview
9.3.2 Business performance
9.3.3 Strategic moves and developments
9.3.4 SWOT analysis of Irvine scientific
9.4 CooperSurgical, Inc. (Origio)
9.4.1 Company overview
9.4.2 Business performance
9.4.3 Strategic moves and developments
9.4.4 SWOT analysis of CooperSurgical, Inc.
9.5 Cook Medical, Inc.
9.5.1 Company overview
9.5.2 Strategic moves and developments
9.5.3 SWOT analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Business performance
9.6.3 Strategic moves and developments
9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Strategic moves and developments
9.7.3 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc.
9.8.1 Company overview
9.8.2 Strategic moves and developments
9.8.2.1 Primary strategies
9.8.2.2 Other strategies
9.8.3 SWOT Analysis of Auxogyn, Inc.
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Strategic moves and developments
9.9.3 SWOT analysis of Oxford Gene Technology
9.10 Ovascience Inc.
9.10.1 Company overview
9.10.2 Business performance
9.10.3 Strategic moves and developments
9.10.4 SWOT analysis of OvaScience, Inc.

List of Tables
Table 1 World Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 2 World Home Decor Market Revenue By Geography, 2014-2020 ($Million)
Table 3 World Furniture Market Revenue By Type, 2014-2020 ($Million)
Table 4 World Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 5 World Kitchen Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 6 World Living & Bedroom Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 7 World Bathroom Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 8 World Outdoor Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 9 World Lighting Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 10 World Home Textile Market Revenue By Type, 2014-2020 ($Million)
Table 11 World Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 12 World Rug Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 13 World Bath Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 14 World Bed Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 15 World Kitchen & Dining Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 16 World Living Room Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 17 World Floor Covering Market Revenue By Type, 2014-2020 ($Million)
Table 18 World Floor Covering Market By Geography, 2014-2020 ($Million)
Table 19 World Tile Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 20 World Wood & Laminate Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 21 World Vinyl & Rubber Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 22 World Carpet & Rugs Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 23 World Other Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 24 North America Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 25 Europe Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 26 Asia-Pacific Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 27 LAMEA Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 28 Snapshot Of Inter Ikea Group
Table 29 Snapshot Of Forbo International Sa
Table 30 Snapshot Of Armstrong World Industries, Inc.
Table 31 Snapshot Of Mannington Mills Inc.
Table 32 Snapshot Of Mohawk Industries Inc.
Table 33 Snapshot Of Shaw Industries
Table 34 Snapshot Of Herman Miller Inc.
Table 35 Snapshot Of Ashley Furniture Industries, Inc.
Table 36 Snapshot Of Kimball International
Table 37 Snapshot Of Duresta Upholstery Ltd.

List of Figures
Fig. 1 IVF Devices And Consumables Market Definition
Fig. 2 Asia-Pacific Adoption Rate By Type Of Surrogacy
Fig. 3 Top Impacting Factors (2014-2020)
Fig. 4 Top Investment Pockets Of Global IVF Devices And Consumables Market (2014-2020)
Fig. 5 Top Winning Strategies In Global IVF Devices And Consumables Market 20122015
Fig. 6 Top Winning Strategies In Global IVF Devices And Consumables Market, 2012-2015
Fig. 7 Porters Five Forces Analysis
Fig. 8 Value Chain Analysis Of Global IVF Market
Fig. 9 Patent Analysis By Type Of Patents (2011-2015)
Fig. 10 Patent Analysis By Geography (2011-2015)
Fig. 11 Effect Of Age On Fertility
Fig. 12 Comparison Of The Media Used In Embryo Culture
Fig. 13 Success Rate Of IVF Techniques Performed By Age, 2013, U.S.
Fig. 14 Pregnancy Rate, Per Frozen Embryo Transfer, 2013 (U.S.)
Fig. 15 Vitrolife Ab, Sales Per Region, 2014
Fig. 16 Vitrolife Ab, Revenues ($Million), 2012-2014
Fig. 17 Swot Analysis Of Vitrolife Ab
Fig. 18 Emd Serono Sales By Region, 2012
Fig. 19 Swot Analysis Of Emd Serono, Inc.
Fig. 20 Swot Analysis Of Irvine Scientific
Fig. 21 Swot Analysis Of Cooper Surgical, Inc.
Fig. 22 Swot Analysis Of Cook Medical, Inc.
Fig. 23 Thermo Fisher Scientific, Inc. Financial Revenues By Business Units (2013)
Fig. 24 Financial Revenues By Geographic Areas (2013)
Fig. 25 Swot Analysis Of Thermo Fisher Scientific, Inc.
Fig. 26 Swot Analysis Of Genea Biomedx
Fig. 27 Swot Analysis Of Auxogyn, Inc.
Fig. 28 Swot Analysis Of Oxford Gene Technology
Fig. 29 Swot Analysis Of Ovascience, Inc.

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Auxogyn Inc.
  • Cook Medical Inc.
  • CooperSurgical
  • EMD Serono
  • Genea Biomedx
  • Irvine Scientific
  • MORE

According to a new report titled, “World In Vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014–2020", global sales of IVF devices and consumables is projected to reach $3 billion by 2020. The IVF disposables and reagent segments collectively accounts for more than three fourth of the market revenue, owing to an increasing number of overall IVF cycles. globally. Europe is the highest revenue generating segment and accounts for around two fifth of the world IVF market share.

In Vitro fertilization (IVF) is a type of assisted reproductive technology, adopted by couples, single mothers, and the LGBT community to deal with infertility conditions. Rising global infertility rates, increasing IVF success rates, and growing per capita healthcare expenditures are boosting the growth of the IVF devices & consumables market. Furthermore, delayed pregnancies and recent innovations in the IVF technology, such as embryoscope and capsule IVF would supplement the market growth. Active government initiatives for LGBT marriages, development of cost-effective IVF procedures and the popularity of fertility tourism is expected to further boost the market growth. However, legal and ethical issues related to IVF treatments, lack of awareness among patients in developing economies, and high costs of IVF devices would limit the market growth.
Capital equipment, such as micromanipulator, IVF cabinets, incubators, and imaging system used in the IVF procedures accounts for the highest share i.e. around 75% in the IVF devices segment. This is attributed to the long shelf-life and high cost related to capital equipment during the IVF procedures. Geographically, Europe would continue to maintain its lead position, owing to the heavy investments made by companies, high affordability, and increasing demand for IVF procedures. This region is expected to grow at a CAGR of 18.2% due to the sophisticated and cost-effective hospitality services and availability of skilled work forces. However, Asia-Pacific is the most lucrative market owing to the rising infertility cases, economic pricing, favorable government regulations, and reimbursements.

Key findings of the study:

- The IVF devices market is expected to grow at a CAGR of 28.4% during the forecast period.
- In the reagents & media segment, cryopreservation media held about 35% of the revenue share in 2015.
- Disposables and consumables used during IVF would remain the highest revenue generating segment throughout the analysis period.
- Fresh IVF cycle was the largest revenue generating IVF technique in 2015 and would continue to maintain this trend untill 2020.
- The IVF clinics segment is expected to be the leading end-users segment through 2020.
Key players operating in this market are largely focusing on product launch as key developmental strategies. Companies are striving to occupy the highest market share through novel product launches such as fully automated vitrification instruments and time-lapse technology.

Leading players profiled in this report are Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn Inc., Oxford Gene Technology, and OvaScience Inc.

Note: Product cover images may vary from those shown
4 of 5

- Auxogyn Inc.
- Cook Medical Inc.
- CooperSurgical
- EMD Serono
- Genea Biomedx
- Irvine Scientific
- OvaScience Inc.
- Oxford Gene Technology
- Thermo Fisher Scientific
- Vitrolife AB

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Cache

Our Clients

  • Actavis
  • Smith & Nephew PLC.
  • Bayer AG
  • Hologic Inc.
  • Abbott Laboratories Ltd.
  • Polpharma SA